Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lung Neoplasms 4Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pituitary Neoplasms 1Neurofibromatoses 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hydrocephalus 1Headache 1Gallbladder Neoplasms 1Female Breast Carcinoma 1Epilepsy 1Disease Progression 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Brain Edema 1Abdominal Neoplasms 1

Interventions

Sevoflurane 1Propofol 1Nitrous Oxide 1Lidocaine 1Glycopyrrolate 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Headache × Sevoflurane × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡